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1 Introduction
Jitteriness in the neonate is a clinical condition
which is described as a symmetrical coarse
tremor of low amplitude and high frequency.
Sometimes the etiology for the jitteriness is
found to be secondary to hypoglycemia, hypo-
calcemia, maternal substance abuse, polycythe-
mia or hypoxic-ischemic encephalopathy [6].
Often the cause, however, cannot be determined
by history or conventional laboratory assess-
ment and the etiology for the majority of cases
of jitteriness remains unclear. Two possible
causes which have not been evaluated for jitteri-
ness in the neonate, but have been recognized as
being capable of producing states of neuronal
hyperexcitability are brain injury [6] and ele-
vated catecholamine levels [2]. The purpose of
this study is to determine if brain injury, or
elevated circulatory levels of catecholamines
may be associated with neonatal jitteriness.
2 Methods
Jitteriness was defined as a generalized and
symmetric movement disorder with a coarse
tremor which can be diminished effectively by
gentle passive flexion.
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At the Los Angeles County-University of
Southern California Medical Center, all jittery
infants are routinely evaluated for hypoglyce-
mia, hypocalcemia, hypomagnesemia, polycy-
themia and electrolyte imbalance. Any jittery
infant who demonstrated any of these dis-
orders, who had evidence of perinatal asphyxia
and/or depression as assessed by Apgar scores
of < 7 or had a history of maternal substance
abuse were excluded. Blood was drawn by ven-
apuncture on all infants. All aspects of the
study were reviewed and approved by the
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Human Subjects Committee of the University
of Southern California School of Medicine and
informed consents were obtained. The infants
were separated into two groups depending on
the presence of jitteriness.
Group A was comprised of thirteen infants who
had jitteriness as their only presenting sign.
Jitteriness was detected at a mean postnatal
age of 1.08 + 0.2 days. Hematocrit and serum
glucose, calcium, phosphate, magnesium, sodi-
um, potassium, and plasma catecholamine
levels were determined at a mean age of
1.27 + 0.4 days of life. Cranial ultrasonogra-
phy was performed on all infants.
' Group B was comprised of twenty-one infants
who were clinically normal and served as the
control group. Blood sampling was done at
1.3 + 0.2 days of life for the same determina-
tions as in Group A. Cranial ultrasonography
was obtained in sixteen of the twenty-one in-
fants.
Cranial ultrasonography was performed with
an ATL ultrasound scanner in three coronal
and three saggital views on 29 of the studied
patients. The images were permanently record-
ed. The scans were evaluated for the presence
of intracranial hemorrhage, which occurs when
significant cerebral blood flow disturbance ex-
ists and is considered a good marker for cere-
bral injury in the neonate [6].
Plasma catecholamines were determined by a
modified microenzymatic radioenzymatic assay
[5]. Sensitivity of the assay was 15 picograms
per ml. for both norepinephrine and epineph-
rine. Determinations were done in one assay to
avoid assay variability.
3 Results
The groups were comparable in gender,
birthweight, gestational age, Apgar scores and
route of delivery (table I). The core tempera-
tures in both groups were normal and compar-
able at birth and at the time of the study. There
were no differences found in the hematocrits,
or serum glucose, calcium, magnesium, sodium,
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Figure 1. Comparison of norepinephrine and epinephri-
ne levels in jittery and control neonates.
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potassium, or phosphate (table II). Cranial ul-
trasonography was normal on all patients
scanned. The plasma norepinephrine level,
however, was found to be significantly elevated
in the jittery group of infants compared to the
control group (figure 1).
4 Discussion
The data from this study indicate that jitteriness
is not related to brain injury, but is associated
with an elevated norepinephrine level. The
reason for this elevation is unclear. Norepi-
nephrine has been identified as the major cate-
cholamine released at birth [1], and perhaps the
exaggerated levels in the jittery neonate is part
of the same process of neonatal adaptation to
extrauterine life. Elevation of norepinephrine
also has been recognized in cold stressed neo-
nates as part of their unique process of non-
shivering thermogenesis. It was not possible in
this study to determine if a thermoregulatory
disturbance induced the elevated levels of nore-
pinephrine since temperature gradients were
not determined. Raised levels of norepinephrine
also have been found to be associated with
increased skeletal muscle activity [2, 3, 4].
It is not possible from this study to identify a
mechanism by which norepinephrine is raised
in the jittery neonate or determine a cause and
effect relationship. We conclude that jitteriness
is not secondary to intracranial hemorrhage,
but is related to increased sympathetic activity.
What influence the increased levels have on
other metabolic and hormonal systems is yet
to be determined.
Summary
Jitteriness is a common problem affecting neonates. Al-
though the cause can sometimes be determined by histo-
ry or conventional laboratory evaluations, nevertheless,
in many instances the cause of the jitteriness is unknown.
To determine if either intracranial hemorrhage (ICH) or
elevated catecholamines are responsible for jitteriness in
neonates, we studied 34 healthy term neonates with
normal hematocrits, serum glucose, Ca, Mg, Na, K and
P. Thirteen of the infants had jitteriness as their only
clinical problem. There were no differences in Apgar
scores, birthweight, or gestational age in the two groups.
Norepinephrine levels were significantly elevated in the
jittery group as compared to the control group:
1276 ± 574 vs. 914 ± 338, p < 0.05. Epinephrine levels
were not different in the two groups. Intracranial hemor-
rhage was not found in any of the patients.
Jittery neonates have increased sympathetic activity.
What influence the increased levels have on other meta-
bolic and hormonal systems is yet to be determined.
Keywords: Catecholamine, intracranial hemorrhage, neonatal jitteriness, norepinephrine.
Zusammenfassung
Tremor unbekannter Ursache beim Neugeborenen und
zirkulierende Katecholamine
Ein Tremor ist ein häufig zu beobachtendes Symptom
beim Neugeborenen. Manchmal kann die Ursache durch
Anamnese oder über laborklinische Parameter geklärt
werden; in vielen Fällen ist die Genese jedoch unbe-
kannt. Um zu bestimmen, ob eine intrakranielle Blutung
(ICH) oder eine erhöhte Katecholaminkonzentration
Ursache des neonatalen Tremors ist, untersuchten wir 34
am Termin geborene Kinder mit normalen Hämatokrit-,
Blutzucker-, Ca++-, Mg++-, N+-, K+- und Phosphat-
werten. Bei 13 Kindern war der Tremor das einzige
klinische Symptom. In Bezug auf den Apgar-Score, das
Geburtsgewicht und das Schwangerschaftsalter gab es
zwischen dem Untersuchungskollektiv und der Kontroll-
gruppe keine Unterschiede.
Der Noradrenalinspiegel war in der Gruppe mit Tremor
signifikant erhöht im Vergleich zur Kontrollgruppe:
1276 ± 574 versus 914 ± 338, p < 0.05. Die Adrenalin-
spiegel unterschieden sich nicht. Eine intrakranielle Blu-
tung wurde bei keinem der Neugeborenen diagnostiziert.
Neugeborene mit Tremor haben eine erhöhte Sympathi-
kus-Aktivität. Es muß untersucht werden, in welcher
Weise dadurch andere metabolische und hormoneile Sy-
steme beeinflußt werden.
Schlüsselwörter: Intrakranielle Blutung, Katecholamine, Noradrenalin, Tremor beim Neugeborenen.
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Resume
Convulsions neo-natales d'origine inconnue et catechola-
mines circulantes
Les convulsions sont un probleme courant affectant
les nouveaux-nes. Dans de nombreux cas, la cause des
convulsions est inconnue, meme si celle-ci peut parfois
etre determinee par I'histoire ou les examens courants
de laboratoire.
Nous avons etudie 34 nouveaux-nes en bonne sante, a
terme, avec hematocrite, glycemie, Ca, Mg, K et P
normaux, pour determiner si soit Phemorragie intra-
cranienne (HIC) soit l'elevation des catecholamines sont
responsables de convulsions chez le nouveau-ne.
Treize enfants ont presente des convulsions comme seul
probleme clinique. II n'y avait pas de difference dans les
scores d'Apgar, le poids de naissance, ni Tage gestationel
dans les deux groupes.
Les taux de norepinephrine etaient eleves de fa$on signi-
ficative dans le groupe avec convulsions en comparaison
du groüpe controle: 1276 ± 574 versus 914 ± 338.
Les taux d'epinephrine n'etaient pas differents dans les
deux groupes. II n'a pas ete trouve d'hemorragie intra-
cranienne chez les patients.
Les nouveaux-nes qui convulsent ont une activite sympa-
thique accrue. II reste encore ä determiner quelle influen-
ce ont les taux eleves süf les autres systemes metaboli-
ques et hormonaux;.
Mots-cles: Catecholamines, convulsions neo-natales, hemorragie intra-cranienne, norepinephrine.
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